Green Cross Health Plans NZ$270m Sale of Medical Division to Tend Health

Strategic Divestment of Medical Division

Green Cross Health Limited (NZX:GXH) has entered a conditional agreement to sell its Medical division, trading as The Doctors, to New Zealand primary care provider Tend Health for NZ$270 million. The deal includes adjustments for net debt and working capital and awaits shareholder approval scheduled for a July meeting. If approved, the transaction is expected to close by the end of July 2026.

The Doctors Network and Ownership Continuity

The Doctors operates 65 clinics across New Zealand, serving over 400,000 enrolled patients, the largest patient base in the country. Tend Health, which also delivers GP services through physical clinics and a nationwide digital platform, is backed by iwi and local investors, ensuring The Doctors remains under New Zealand ownership. This continuity may ease concerns about the division's future direction under new stewardship.

Refocusing on Pharmacy and Capital Allocation

Following the sale, Green Cross Health will concentrate on its pharmacy operations, which include the Unichem and Life Pharmacy brands. The Board has indicated it will consider how best to deploy the sale proceeds, weighing options between reinvesting in pharmacy growth and returning capital to shareholders. This marks a clear strategic pivot towards the company’s core pharmacy business after a period of growth in both medical and pharmacy segments, with the medical division having contributed to a 33% profit surge recently.

Uncertainties and Next Steps

While the sale price is set at NZ$270 million, final adjustments for net debt and working capital introduce some uncertainty around the ultimate proceeds. The critical next milestone is the shareholder vote, which will determine whether the deal proceeds as planned. Investors should also watch for the Board’s decisions on capital allocation post-completion, as these will signal Green Cross Health’s priorities and potential returns to shareholders.

This move follows earlier talks about a possible sale of the Medical division, where no deal certainty had been given, reflecting a considered and deliberate approach by Green Cross Health to reshape its business focus.